Major Gastroenterology Journal Accepts Version 2 Technology Study For Publication

EXACT Sciences Corporation (NASDAQ: EXAS) announced that a major gastroenterology journal has accepted for publication a multi-center, prospective study of EXACT’s Version 2 technology for early colorectal cancer detection using stool-based DNA testing. The study, conducted by Steven H. Itzkowitz, M.D, Professor of Medicine, Mount Sinai School of Medicine and his collaborators, was also recently presented in abstract form at Digestive Disease Week (DDW) in San Diego, California.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on June 19th, 2008